{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:51:36Z","timestamp":1792428696811,"version":"4.5.0"},"reference-count":4,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.urology.2019.06.033","type":"journal-article","created":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T11:43:44Z","timestamp":1562672624000},"page":"210-211","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Intravesical Electromotive Botulinum Toxin Type A (Dysport) Administration in Children With Myelomeningocele"],"prefix":"10.1016","volume":"132","author":[{"given":"Lida","family":"Sharifi-Rad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyedeh-Sanam","family":"Ladi-Seyedian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behnam","family":"Nabavizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Alijani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdol-Mohammad","family":"Kajbafzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2019.06.033_bib0001","doi-asserted-by":"crossref","first-page":"e2309","DOI":"10.7717\/peerj.2309","article-title":"Investigation of the mechanisms of action behind Electromotive Drug Administration (EMDA)","volume":"4","author":"Kos","year":"2016","journal-title":"PeerJ"},{"key":"10.1016\/j.urology.2019.06.033_bib0002","series-title":"The Use of the Electromotive Drug Administration System in Patients with Overactive Bladder: A Review of the Clinical Effectiveness, Safety, and Cost-Effectiveness","year":"2014"},{"key":"10.1016\/j.urology.2019.06.033_bib0003","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.urology.2010.06.003","article-title":"Intravesical electromotive botulinum toxin type A administration \u2013 part II: clinical application","volume":"77","author":"Kajbafzadeh","year":"2011","journal-title":"Urology"},{"key":"10.1016\/j.urology.2019.06.033_bib0004","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.urology.2017.11.039","article-title":"Intravesical electromotive botulinum toxin type \"A\" administration for management of urinary incontinence secondary to neuropathic detrusor overactivity in children: long-term follow-up","volume":"114","author":"Ladi-Seyedian","year":"2018","journal-title":"Urology"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429519306090?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429519306090?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T04:02:11Z","timestamp":1570161731000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429519306090"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":4,"alternative-id":["S0090429519306090"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2019.06.033","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravesical Electromotive Botulinum Toxin Type A (Dysport) Administration in Children With Myelomeningocele","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2019.06.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}